1312 days ago
OptiBiotix Health (OPTI) is “pleased to announce… an exclusive distribution agreement with Ayalla Marketing for the distribution of its cholesterol reducing probiotic, LPLDL®, as an ingredient and as four finished products (CholBiome, CholBiomeX3, CholBiomeBP and CholBiomeVH) within the CholBiome® portfolio for Brazil”…
1781 days ago
More positive news from OptiBiotix Health (OPTI)?… The company has announced an exclusive license agreement for the commercialisation of, currently fully-owned subsidiary, ProBiotix’s cholesterol management products CholBiome and CholBiomex3 in Vietnam…
1932 days ago
The latest deal from Optibiotix (OPTI) is a three year distribution agreement with a company called SilvEXPO Ltd to distribute and commercialise OptiBiotix's own label CholBiome products containing its cholesterol and blood pressure reducing LPLDL strain in Russia and Kazakhstan.
